{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T21:47:18Z","timestamp":1782164838061,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":3138,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1593\/neo.05304","type":"journal-article","created":{"date-parts":[[2005,10,27]],"date-time":"2005-10-27T21:00:42Z","timestamp":1130446842000},"page":"957-966","source":"Crossref","is-referenced-by-count":15,"title":["Vascular Targeting in Pancreatic Cancer: The Novel Tubulin-Binding Agent ZD6126 Reveals Antitumor Activity in Primary and Metastatic Tumor Models"],"prefix":"10.1016","volume":"7","author":[{"given":"Axel","family":"Kleespies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"K\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Barge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Walter","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane J.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.05304_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1259\/0007-1285-66-783-181","article-title":"Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy","volume":"66","author":"Denekamp","year":"1993","journal-title":"Br J Radiol"},{"key":"10.1593\/neo.05304_bib2","first-page":"1757","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston","volume":"333","author":"Folkman","year":"1995","journal-title":"Clinical applications of research on angiogenesis. N Engl J Med"},{"issue":"Suppl 1","key":"10.1593\/neo.05304_bib3","first-page":"57","article-title":"Tumour vasculature as a target for cancer therapy","volume":"80","author":"Chaplin","year":"1999","journal-title":"BrJ Cancer"},{"key":"10.1593\/neo.05304_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1158\/1078-0432.CCR-0642-03","article-title":"Vascular targeting agents as cancer therapeutics","volume":"10","author":"Thorpe","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib5","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/cncr.20299","article-title":"Vasculartargeting therapies for treatment of malignant disease","volume":"100","author":"Siemann","year":"2004","journal-title":"Cancer"},{"key":"10.1593\/neo.05304_bib6","first-page":"7247","article-title":"ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature","volume":"62","author":"Davis","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.05304_bib7","first-page":"1534","article-title":"Vascular-targeting activity of ZD6126, a novel tubulin-binding agent","volume":"63","author":"Micheletti","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.05304_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/jnci\/82.15.1247","article-title":"Taxol: a novel investigational antimicrotubule agent","volume":"62","author":"Rowinsky","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.05304_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.2910630121","article-title":"Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid","volume":"63","author":"Hill","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.05304_bib10","first-page":"1974","article-title":"Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models","volume":"6","author":"Blakey","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0360-3016(03)00769-7","article-title":"Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response","volume":"57","author":"Horsman","year":"2003","journal-title":"Int J Radiat Oncol Biel Phys"},{"key":"10.1593\/neo.05304_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10456-004-1941-3","article-title":"In viva videomicroscopy reveals differential effects of the vascular-targeting agent ZD6126 and the anti angiogenic agent ZD6474 on vascular function in a liver metastasis model","volume":"7","author":"Varghese","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1593\/neo.05304_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4161\/cbt.3.10.1135","volume":"3","author":"Raben","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1593\/neo.05304_bib14","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1158\/1078-0432.CCR-04-1171","article-title":"Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin","volume":"10","author":"Goto","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1078-0432.835.11.2","article-title":"Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma","volume":"11","author":"Wachsberger","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00001622-200207000-00010","article-title":"Update on pancreatic cancer","volume":"14","author":"Rocha Lima","year":"2002","journal-title":"Carr Opin Oncol"},{"key":"10.1593\/neo.05304_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.neo.7900005","article-title":"In viva selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice","volume":"1","author":"Bruns","year":"1999","journal-title":"Neoplasia"},{"key":"10.1593\/neo.05304_bib18","first-page":"1182","article-title":"Antiangiogenic and antitumor activity of ON 5390, a new taxane derivative","volume":"6","author":"Tarboletti","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib19","first-page":"1534","article-title":"Vascular targeting activity of ZD6126, a novel tubulin binding agent","volume":"63","author":"Micheletti","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.05304_bib20","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1158\/1078-0432.CCR-04-0621","article-title":"Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice","volume":"10","author":"Vezhelyev","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib21","first-page":"1592","article-title":"Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging","volume":"88","author":"Robinson","year":"2003","journal-title":"BrJCancer"},{"key":"10.1593\/neo.05304_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.10681","article-title":"Effectofthevascu lar endothelial growth factor receptor-2 antibody DC 101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice","volume":"102","author":"Bruns","year":"2002","journal-title":"Int JCancer"},{"key":"10.1593\/neo.05304_bib23","first-page":"2926","article-title":"Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma","volume":"60","author":"Bruns","year":"2000","journal-title":"Cancer Res"},{"key":"10.1593\/neo.05304_bib24","first-page":"1898","article-title":"Quantitative analysis of microvascular structure and function in the amelanotic melanoma A-Mel-3","volume":"41","author":"Asaishi","year":"1981","journal-title":"Cancer Res"},{"key":"10.1593\/neo.05304_bib25","first-page":"1575","article-title":"A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis","volume":"61","author":"Guba","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.05304_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"6","author":"Guba","year":"2002","journal-title":"Nat Med"},{"key":"10.1593\/neo.05304_bib27","first-page":"783","article-title":"Lack of neurotoxicity of the vascular i.v","volume":"3","author":"Horner","year":"2004","journal-title":"dosing in the rat. MolCancer Ther"},{"key":"10.1593\/neo.05304_bib28","first-page":"95","article-title":"Vascular endothelial growth factor in esophageal cancer","volume":"167","author":"Kleespies","year":"2004","journal-title":"J SurgOnco"},{"key":"10.1593\/neo.05304_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1593\/neo.05304_bib30","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/1078-0432.CCR-03-0417","article-title":"Magnetic resonance imaging measurements of the response of murine and hu man tumors to the vascular-targeting agent ZD6126","volume":"10","author":"Evelhoch","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.05304_bib31","first-page":"705","article-title":"ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer","volume":"90","author":"McCarty","year":"2004","journal-title":"BrJCancer"},{"key":"10.1593\/neo.05304_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1535-6108(02)00051-X","article-title":"Molecular mechanisms of lymphangiogenesis in health and disease","volume":"1","author":"Alitalo","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.05304_bib33","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1126\/science.1071420","article-title":"Lymphatic metastasis in the absence of functional intratumor lymphatics","volume":"296","author":"Faders","year":"2002","journal-title":"Science"},{"key":"10.1593\/neo.05304_bib34","first-page":"359","article-title":"Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787\/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases","volume":"16","author":"Solorzano","year":"2001","journal-title":"Cancer BiotherRadiopharm"},{"key":"10.1593\/neo.05304_bib35","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0360-3016(02)03919-6","article-title":"Antitumor efficacy of conventional anticancer drugs is enhanced by the vascular targeting agent ZD6126","volume":"54","author":"Siemann","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558605801198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558605801198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T06:39:00Z","timestamp":1683268740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558605801198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1476558605801198"],"URL":"https:\/\/doi.org\/10.1593\/neo.05304","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}